scholarly article | Q13442814 |
P50 | author | Miklós Sahin-Tóth | Q38318675 |
Heiko Witt | Q90796906 | ||
P2093 | author name string | András Szabó | |
Eszter Hegyi | |||
Maren Ludwig | |||
Renata Szépeová | |||
P2860 | cites work | Human Mesotrypsin Is a Unique Digestive Protease Specialized for the Degradation of Trypsin Inhibitors | Q24295201 |
Mesotrypsin: a new inhibitor-resistant protease from a zymogen in human pancreatic tissue and fluid | Q24301887 | ||
Molecular cloning and expression of human caldecrin | Q24312209 | ||
Identification and expression of the cDNA-encoding human mesotrypsin(ogen), an isoform of trypsin with inhibitor resistance | Q24312765 | ||
Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis | Q24645261 | ||
Chymotrypsin C (caldecrin) promotes degradation of human cationic trypsin: identity with Rinderknecht's enzyme Y | Q24675338 | ||
The role of ecotin dimerization in protease inhibition | Q27631754 | ||
Crystal structure reveals basis for the inhibitor resistance of human brain trypsin | Q27637610 | ||
Structural basis for accelerated cleavage of bovine pancreatic trypsin inhibitor (BPTI) by human mesotrypsin | Q27649308 | ||
Determinants of Affinity and Proteolytic Stability in Interactions of Kunitz Family Protease Inhibitors with Mesotrypsin | Q27664637 | ||
The P 2 ′ residue is a key determinant of mesotrypsin specificity: engineering a high-affinity inhibitor with anticancer activity | Q27671330 | ||
Long-range Electrostatic Complementarity Governs Substrate Recognition by Human Chymotrypsin C, a Key Regulator of Digestive Enzyme Activation | Q27676497 | ||
Presence versus absence of hydrogen bond donor Tyr-39 influences interactions of cationic trypsin and mesotrypsin with protein protease inhibitors | Q27679201 | ||
Sequence and conformational specificity in substrate recognition: several human Kunitz protease inhibitor domains are specific substrates of mesotrypsin. | Q30367678 | ||
The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin | Q33581987 | ||
Pancreatitis-associated chymotrypsinogen C (CTRC) mutant elicits endoplasmic reticulum stress in pancreatic acinar cells | Q33764920 | ||
High affinity small protein inhibitors of human chymotrypsin C (CTRC) selected by phage display reveal unusual preference for P4' acidic residues | Q33880616 | ||
Trypsinogen variants in pancreatic juice of healthy volunteers, chronic alcoholics, and patients with pancreatitis and cancer of the pancreas | Q34476170 | ||
Chymotrypsin C is a co-activator of human pancreatic procarboxypeptidases A1 and A2. | Q34503091 | ||
Association of rare chymotrypsinogen C (CTRC) gene variations in patients with idiopathic chronic pancreatitis | Q34732835 | ||
Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C | Q36016998 | ||
Zymogen activation confers thermodynamic stability on a key peptide bond and protects human cationic trypsin from degradation. | Q37596314 | ||
Chymotrypsin C (caldecrin) stimulates autoactivation of human cationic trypsinogen | Q38290039 | ||
Comprehensive screening of chymotrypsin C (CTRC) gene in tropical calcific pancreatitis identifies novel variants | Q39334642 | ||
Comprehensive functional analysis of chymotrypsin C (CTRC) variants reveals distinct loss-of-function mechanisms associated with pancreatitis risk | Q40906883 | ||
The sequence and reactive site of ecotin. A general inhibitor of pancreatic serine proteases from Escherichia coli | Q42144510 | ||
Robust autoactivation, chymotrypsin C independence and diminished secretion define a subset of hereditary pancreatitis-associated cationic trypsinogen mutants. | Q42145402 | ||
Sequence determination of eglin C using combined microtechniques of amino acid analysis, peptide isolation, and automatic Edman degradation | Q42260195 | ||
Determinants of chymotrypsin C cleavage specificity in the calcium-binding loop of human cationic trypsinogen. | Q43246426 | ||
Identification of novel missense CTRC variants in Japanese patients with chronic pancreatitis | Q45140102 | ||
Affinity purification of recombinant trypsinogen using immobilized ecotin. | Q46011088 | ||
CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis: is the role of mutated CFTR overestimated? | Q46039599 | ||
Effects of chronic alcohol abuse on exocrine pancreatic secretion in man | Q70044313 | ||
Purification from Escherichia coli of a periplasmic protein that is a potent inhibitor of pancreatic proteases | Q70445331 | ||
Arazoformyl peptide surrogates as spectrophotometric kinetic assay substrates for carboxypeptidase A | Q71543383 | ||
Engineered eglin c variants inhibit yeast and human proprotein processing proteases, Kex2 and furin | Q73270037 | ||
CHYMOTRYPSIN C. I. ISOLATION OF THE ZYMOGEN AND THE ACTIVE ENZYME: PRELIMINARY STRUCTURE AND SPECIFICITY STUDIES | Q77193324 | ||
CHYMOTRYPSIN C. II. ENZYMATIC SPECIFICITY TOWARD SEVERAL POLYPEPTIDES | Q77193331 | ||
Active forms of chymotrypsin C isolated from autolyzed porcine pancreas glands | Q93611004 | ||
P433 | issue | 28 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 11 | |
P304 | page(s) | 17282-17292 | |
P577 | publication date | 2015-05-26 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | Mesotrypsin Signature Mutation in a Chymotrypsin C (CTRC) Variant Associated with Chronic Pancreatitis | |
P478 | volume | 290 |
Q38805333 | Causal Evaluation of Acute Recurrent and Chronic Pancreatitis in Children: Consensus From the INSPPIRE Group. |
Q38875996 | Clinical chronic pancreatitis |
Q33843764 | Genetic Risk in Chronic Pancreatitis: The Trypsin-Dependent Pathway |
Q97548636 | Loss of chymotrypsin-like protease (CTRL) alters intrapancreatic protease activation but not pancreatitis severity in mice |
Q37231509 | PRSS1, SPINK1, CFTR, and CTRC Pathogenic Variants in Korean Patients With Idiopathic Pancreatitis |
Q33591558 | PRSS3 is a prognostic marker in invasive ductal carcinoma of the breast |